2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Metil)-4-fluorobenzonitrile

2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile digunakake minangka perantara Trelagliptin succinate.

Trogliptin succinate minangka inhibitor dipeptidyl peptidase Ⅳ (DPP - Ⅳ) sing dikembangake dening Takeda (Takeda Pharmaceutical Co., Ltd.) ing Jepang.Bisa selektif lan terus-terusan nyandhet DPP - Ⅳ lan ngontrol tingkat glukosa getih.Uji klinis nuduhake yen obat kasebut nduweni safety lan efektifitas sing apik.Seminggu sepisan bisa ngontrol tingkat glukosa getih kanthi efektif lan nambah kepatuhan obat pasien.Ing Mei, 2015, obat kasebut disetujoni dening PMDA Jepang kanggo didaftar kanggo perawatan diabetes.